Company
ADARx Pharmaceuticals
| Industry | clinical stage biotechnology company developing RNA-targeting therapeutics |
|---|
Funding raised
| Round | Date |
|---|---|
| Series C Financing | 2023-08-10 |
| Series B-1 | 2023-01-20 |
Company
| Industry | clinical stage biotechnology company developing RNA-targeting therapeutics |
|---|
| Round | Date |
|---|---|
| Series C Financing | 2023-08-10 |
| Series B-1 | 2023-01-20 |